HOLZMINDEN (dpa-AFX) - Symrise AG announced that it is in advanced discussions with potential buyers regarding the divestment of its terpenes business. The process is being conducted as a structured bidding procedure. Based on the offers received to date, the company will apply the international accounting standard IFRS 5. In this context, Symrise AG will record a non-cash impairment charge of approximately 145 million euros in the fourth quarter of 2025, which will negatively impact its EBIT.
In addition, Symrise AG's investment in Sweden-listed Swedencare AB is subject to a non-cash impairment. Preliminary calculations indicate that this adjustment will result in a material deviation from the company's expected financial results for 2025 compared to current capital market expectations and its published forecast. Symrise AG will record a non-cash impairment charge of 150 million euros related to this investment in the fourth quarter of 2025, which will negatively affect EBITDA.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
